What's new

Barkat Ventures delivers the first batch of covid-19 vaccines to the Iranian Ministry of Health

In few days, Pasteur institute's vaccine (joint project with Cuba) will receive it's permission for public usage too, health ministry announced it's effectiveness against South African and Brazilian variants of Corona virus about 62%, about 6 times higher than AstraZeneca vaccine with 11% effectiveness rate!

نمکی: واکسن پاستور سه‌شنبه مجوز مصرف اورژانسی می‌گیرد- اخبار پزشکی - اخبار اجتماعی تسنیم | Tasnim
I don't consider That vaccine Iranian or a joint project. It's Cuban (Soberna 2) vaccine that institute pasteur agreed to test its pase 3 in Iran instead receive the permission to produce it. While its good move but I expected institute pasteur like Razi vaccine and serum making or Barkat institute or defence ministry at least tried to produce an Iranian designed vaccine.
 
.
I don't consider That vaccine Iranian or a joint project. It's Cuban (Soberna 2) vaccine that institute pasteur agreed to test its pase 3 in Iran instead receive the permission to produce it. While its good move but I expected institute pasteur like Razi vaccine and serum making or Barkat institute or defence ministry at least tried to produce an Iranian designed vaccine.
It was technology transfer, other institutes had taken different methods, but considering the needed time and possible failure, plus good history of cooperation with Cuba I believe ultimately their decision was correct.
 
.
It was technology transfer, other institutes had taken different methods, but considering the needed time and possible failure, plus good history of cooperation with Cuba I believe ultimately their decision was correct.
Still Cuban vaccine , and as far as I'm aware its not transfer of technology its transfer of a production line.

about cooperation history well I can't say much , they share some of our problem and we see some matters in the same light but we don't have that much interaction.
about this vaccine , Cuba have problem mass producing this vaccine for it's citizen because of financial issue , we could help them on that front and get the technology of producing such vaccine instead of testing it and get a production line. if we call that vaccine cooperation between Cuba and Iran then are you ready to call Sputnick-V vaccines that are supposed to be produced in Iran a transfer of technology and joint project between Iran and Russia
 
.
Still Cuban vaccine , and as far as I'm aware its not transfer of technology its transfer of a production line.

about cooperation history well I can't say much , they share some of our problem and we see some matters in the same light but we don't have that much interaction.
about this vaccine , Cuba have problem mass producing this vaccine for it's citizen because of financial issue , we could help them on that front and get the technology of producing such vaccine instead of testing it and get a production line. if we call that vaccine cooperation between Cuba and Iran then are you ready to call Sputnick-V vaccines that are supposed to be produced in Iran a transfer of technology and joint project between Iran and Russia
Transfer of technology was the condition for this cooperation:
واکسیناسیون عمومی با واکسن ایرانی کوبایی در انتظار تایید اثربخشی | خبرگزاری صدا و سیما

In the past, Cuba has sold their vaccine along TOT with 1/10 price of the European countries who weren't even committed to the delivery schedule:

3159809.jpg

3159810.jpg
 
.
Iran’s Supreme Leader Khamenei receives local COVID vaccine


1228392_557.jpg


Human trials on the COVIran Barekat vaccine began in late December and about 24,000 volunteers have received jabs as part of a third phase of trials that recently concluded.

Tehran, Iran – Iran’s Supreme Leader Ali Hosseini Khamenei has received a dose of the country’s first locally developed COVID-19 vaccine.

Khamenei on Friday called the development of the vaccine a point of “national pride”.

“Some insisted from a while ago that I use a vaccine,” the 82-year-old, who has had a string of previous health problems, said after receiving the first dose of the jab called COVIran Barekat.

“I didn’t want to use a non-Iranian vaccine. I said we will wait until, inshallah, the local vaccine is produced and we can use our own vaccine,” he said.

The supreme leader had in January outlawed the use of United States and United Kingdom-made vaccines, notably those developed by Pfizer and Moderna, as he said they “cannot be trusted”.

Human trials on the COVIran Barekat vaccine began in late December and about 24,000 volunteers received jabs as part of its third phase of trials that recently concluded.

The vaccine received an emergency use authorisation earlier this month and is expected to be rolled out on a large scale in the coming weeks.

Setad, a powerful organisation under the supreme leader that is in charge of developing the vaccine, has said it now produces three million doses per month and will soon boost production to 11 million doses a month to become the largest vaccine manufacturer in the Middle East.

While the vaccine’s detailed scientific data have not been made public and subjected to peer reviews, its developers have claimed it was 93.5 percent effective among individuals 18 to 75 in its second phase of human trials.

They have also claimed 12 countries from Asia, South America and Europe wish to buy the vaccine, without naming them.

Vaccination efforts still lagging

Iran recently managed to control a fourth deadly wave of the coronavirus that has so far killed more than 83,000 people in what has become the deadliest pandemic of the Middle East.

Health officials are already sounding out the alarm over a fifth potential wave of the virus.

Even as Iran has imported millions of doses of foreign vaccines, it had mainly banked on local jabs to inoculate most of its 83 million population.

Doses have been imported from Russia, China, India, and through the global vaccine initiative under the World Health Organization known as COVAX.

However, amid money transfer issues caused by United States sanctions, imports have lagged, resulting in a slow vaccination effort and significant gaps between administering the first and second doses.

According to the latest figures released by the health ministry, so far just over five percent of the total population has been vaccinated.

Videos have also circulated online showing some vaccination centres have been met with high demand, leading to hours-long waiting times and far-stretching queues of elderly and vulnerable Iranians.

Kianush Jahanpur, the spokesman for Iran’s Food and Drug Administration, attracted much criticism and calls for his resignation when on Thursday he called people who have criticised the lagging vaccine efforts “dastards”.

Other Iranian vaccines on the way

COVIran Barekat is soon expected to be rolled out while several other locally developed vaccines are in various stages of development.

A vaccine developed by Iran’s Pasteur Institute in collaboration with Cuba is finishing its third phase of human trials in several cities across Iran and is expected to receive an emergency use authorisation soon. It is said to be 62 percent effective.

Razi COV-Pars, a vaccine developed by the Razi Vaccine and Serum Research Institute, is also undergoing its third phase of human trials and is expected to be approved in the coming weeks.

An organisation under Iran’s defence ministry has also developed a vaccine called Fakhravac in honour of Mohsen Fakhrizadeh, a nuclear scientist who was assassinated in November in an attack blamed on Israel.

This comes as the Islamic Revolutionary Guard Corps (IRGC) has announced it will soon unveil a vaccine developed by its scientists.

At least one vaccine developed by Iran’s private sector is also undergoing human trials.

Health ministry officials have expressed hope that the jab developed by biotechnology firm CinnaGen can clear human trials successfully in the coming months.

Health Minister Saeed Namaki also announced earlier this week that Iran will unveil its locally produced version of Russia’s Sputnik V vaccine on Saturday.

Iran had started its vaccination efforts with the Russian jab from February.
 
. . .
At least one vaccine developed by Iran’s private sector is also undergoing human trials.

Health ministry officials have expressed hope that the jab developed by biotechnology firm CinnaGen can clear human trials successfully in the coming months.
that's not an Iranian vaccine , CinnaGen an Iranian BioTechnology company made a deal with an Australian company named "Vaxine" to test its monovalent recombinant Covid-19 vaccine for Phase II and III human trial and instead get the right to produce and sell their vaccine under the brand of SpikoGen.

to be honest I don't think it will result in something spectacular as these type of vaccines didn't showed much promise for Covid-19
 
. .
More good news. Beside UK variant, CovoIran Barakat vaccine has shown effectiveness against South African variant of corona virus too.

3185025.jpg
 
.
that's not an Iranian vaccine , CinnaGen an Iranian BioTechnology company made a deal with an Australian company named "Vaxine" to test its monovalent recombinant Covid-19 vaccine for Phase II and III human trial and instead get the right to produce and sell their vaccine under the brand of SpikoGen.

In other terms, using Iranians as guinea pigs for an obscure Australian company's vaccine... Why the heck won't they test it on Australians? Iran should pass a law prohibiting this shameful practice of using Iranians as test subjects for the global pharmaceutical industries.
 
.
In other terms, using Iranians as guinea pigs for an obscure Australian company's vaccine... Why the heck won't they test it on Australians? Iran should pass a law prohibiting this shameful practice of using Iranians as test subjects for the global pharmaceutical industries.
well , they promised not to do that , but what I can say. it happened in two case . first Institute Pasteur did this by testing Phase 3 of Cuban Soberna-2 vaccine in Iran and then CinnaGen biotechnology did that by testing phase 2 and 3 of that vaccine candidate from Australian company Vaxine .
it seems their promise only was limited to the first phase of the tests if we did have not our own vaccine it was understandable while in fact we have 4 vaccine made by ourselves (COVIran Barakat, Razi Cov Pars, FAKHRAVAC, Noora Vaccine) and we have contract to produce one foreign proven vaccine (Sputnik-V produced by Actover-Iran under license) we were not that desperate , I really can't understand it.
 
Last edited:
.
well , they promised not to do that , but what I can say. it happened in two case . first Institute Pasteur did this by testing Phase 3 of Cuban Soberna-2 vaccine in Iran and then CinnaGen biotechnology did that by testing phase 2 and 3 of that vaccine candidate from Australian company Vaxine .
it seems their promise only was limited to the first phase of the tests if we did have not our own vaccine it was understandable while in fact we have 4 vaccine made by ourselves (COVIran Barakat, Razi Cov Pars, FAKHRAVAC, Noora Vaccine) and we have contract to produce one foreign proven vaccine (Sputnik-V produced by Actover-Iran under license) we were not that desperate , I really can't understand it.

In this regard Cuba's advantage is its socialist nature. Cuban pharmaceutical manufacturers are not primarily motivated by profit maximization and therefore less prone to trying to cover up possible adverse effects of their products, as opposed to their counterparts in the cut-throat capitalist world.

So while the Cubans can hardly be suspected of being on the lookout for "guinea pigs" outside their borders, we can't be too sure about some Australian company. But at least they conducted the phase I trials on local Australians. Generally speaking, it is typically pharmaceutical companies from developed countries which like to test their new products on people in the global south, with defenceless and impoverished Africans being the most affected by these dubious practices.
 
Last edited:
.
In this regard Cuba's advantage is its socialist nature. Cuban pharmaceutical manufacturers are not primarily motivated by profit maximization and therefore less prone to trying to cover up possible adverse effects of their products, as opposed to their counterparts in the cut-throat capitalist world.

So while the Cubans can hardly be suspected of being on the lookout for "guinea pigs" beyond their borders, we can't be too sure about some Australian company. But at least they conducted the phase I trials on locals Australians. Generally speaking, it is typically pharmaceutical companies from developed countries which like to test their new products on people in the global south, with defenceless and impoverished Africans being the most affected by these dubious practices.
you see the first phase is safety phases the second and third phase of human trial are efficacy test.
my problem is not with testing those vaccine in Iran , my problem is why we did made such deal when we have the capacity to build our vaccine , and our vaccine is better than the vaccines 3/4th of the world use. or example that soberna vaccine strength is only it cover Brazilian variant to some extent (50-60%) against all other variant CovIran-Barkat is superior by 10-20% .
it's not the matter of the company is trustworthy or not.
Pasteur institute and CinnaGen Biotechnique capability to produce the vaccine is limited and I doubt they can offer that much to Iran Vaccine Market and I'm not exactly how is their deal , but Actover-Iran deal with russia seems to have a clause that part of the vaccine produced (nearly half) must be for Russia market. wonder what's your idea about that
 
.
More good news. Beside UK variant, CovoIran Barakat vaccine has shown effectiveness against South African variant of corona virus too.

3185025.jpg
when is it gonna get started? mass vaccination? for a person like me whom has tried to follow protocols since early Esfand 98 it is getting annoying ...
 
.

Pakistan Affairs Latest Posts

Back
Top Bottom